ASPARAGINASE-SPECIFIC ANTIBODY MEASUREMENT IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) UNDER NATIVE E. COLI ASPARAGINASE-BASED AND ITS POTENTIAL FACTORS ASSOCIATION

被引：0
|
作者：
Techavichit, Piti [1 ]
Chaweephisal, Phumin [1 ]
Poparn, Hansamon [1 ]
Chiengthong, Kanhatai [1 ]
Lauhasurayotin, Supanun [1 ]
Sosothikul, Darintr [1 ]
机构：
[1] Dept Pediat, Integrat & Innovat Hematol Oncol Res Unit, Bangkok, Thailand
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP072
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Multiple Doses of Intravenous Pegylated Asparaginase with a "Pediatric-like" Protocol in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): Toxicity, Clinical Outcome and Low Rate of Anti Asparaginase Antibody Formation.
    Douer, Dan
    Watkins, Kristy
    Mark, Lisa
    Vrona, Janice
    Mohrbacher, Ann
    Yang, Allen S.
    Avramis, Vassilos I.
    BLOOD, 2009, 114 (22) : 1199 - 1199
  • [42] Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002
    Alexander Karachunskiy
    Gesche Tallen
    Julia Roumiantseva
    Svetlana Lagoiko
    Almira Chervova
    Arend von Stackelberg
    Olga Aleinikova
    Oleg Bydanov
    Lyudmila Bajdun
    Tatiana Nasedkina
    Natalia Korepanova
    Sergei Kuznetsov
    Galina Novichkova
    Marina Goroshkova
    Dmitry Litvinov
    Natalia Myakova
    Natalia Ponomareva
    Evgeniya Inyushkina
    Konstantin Kondratchik
    Julia Abugova
    Larisa Fechina
    Oleg Arakaev
    Alexander Karelin
    Vladimir Lebedev
    Natalia Judina
    Gusel Scharapova
    Irina Spichak
    Anastasia Shamardina
    Olga Ryskal
    Alexander Shapochnik
    Alexander Rumjanzew
    Joachim Boos
    Günter Henze
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 1001 - 1012
  • [43] Is it Ethical in Low and Middle-Income Countries to Continue the use of E. coli L-Asparaginase in Patients with Acute Lymphoblastic Leukemia? Analysis made in Mexico
    Aguillen Jimenez, E. G.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S97 - S97
  • [44] Thrombin Generation Assay Proved the Increasing Thrombin Production After Native Escherichia coli Asparaginase in Pediatric Acute Lymphoblastic Leukemia According to ThaiPOG2021 Protocol
    Torchareon, Teesit
    Chaweephisal, Phumin
    Akkawat, Benjaporn
    Sosothikul, Darintr
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (08) : E1035 - E1037
  • [45] Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow-Berlin 2002
    Karachunskiy, Alexander
    Tallen, Gesche
    Roumiantseva, Julia
    Lagoiko, Svetlana
    Chervova, Almira
    von Stackelberg, Arend
    Aleinikova, Olga
    Bydanov, Oleg
    Bajdun, Lyudmila
    Nasedkina, Tatiana
    Korepanova, Natalia
    Kuznetsov, Sergei
    Novichkova, Galina
    Goroshkova, Marina
    Litvinov, Dmitry
    Myakova, Natalia
    Ponomareva, Natalia
    Inyushkina, Evgeniya
    Kondratchik, Konstantin
    Abugova, Julia
    Fechina, Larisa
    Arakaev, Oleg
    Karelin, Alexander
    Lebedev, Vladimir
    Judina, Natalia
    Scharapova, Gusel
    Spichak, Irina
    Shamardina, Anastasia
    Ryskal, Olga
    Shapochnik, Alexander
    Rumjanzew, Alexander
    Boos, Joachim
    Henze, Guenter
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (04) : 1001 - 1012
  • [46] Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation
    Henriksen, Louise Tram
    Hojfeldt, Sofie Gottschalk
    Schmiegelow, Kjeld
    Frandsen, Thomas Leth
    Wehner, Peder Skov
    Schroder, Henrik
    Albertsen, Birgitte Klug
    PEDIATRIC BLOOD & CANCER, 2017, 64 (12)
  • [47] Outcomes following discontinuation of E. coli L-asparaginase upon severe allergic reactions in children with acute lymphoblastic leukemia (vol 63, pg 665, 2016)
    Yen, H-J
    Chang, W-H
    Liu, H-C
    Yeh, T-C
    Hung, G-Y
    Wu, K-H
    Peng, C-T
    Chang, Y-H
    Chang, T-K
    Hsiao, C-C
    Sheen, J-M
    Chao, Y-H
    Chang, T-T
    Chiou, S-S
    Lin, P-C
    Wang, S-C
    Lin, M-T
    Ho, W-L
    Chen, Y-C
    Liang, D-C
    PEDIATRIC BLOOD & CANCER, 2016, 63 (06) : 1131 - 1131
  • [48] Plasma asparaginase activity and asparagine depletion in patients with acute lymphoblastic leukemia (ALL) treated with pegaspargase (SS-PEG E. coli L-asparaginase): Results from Children's Oncology Group (COG) study AALLO7P4.
    Schore, Reuven J.
    Devidas, Meenakshi
    Bleyer, Archie
    Reaman, Gregory H.
    Winick, Naomi J.
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Carroll, William L.
    Hunger, Stephen
    Angiolillo, Anne L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Pharmacokinetics-Based Modification of Intravenous Pegylated Asparaginase Dosing in the Context of a "Pediatric-inspired" Protocol in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
    Douer, Dan
    Aldoss, Ibrahim
    Lunning, Matthew A.
    Ramezani, Laleh
    Burke, Patrick
    Mark, Lisa
    Vrona, Janice
    Park, Jae H.
    Tallman, Martin S.
    Pullarkat, Vinod
    Mohrbacher, Ann M.
    Avramis, Vassilos I.
    BLOOD, 2012, 120 (21)
  • [50] Initial Results from a Phase 2/3 Study of Recombinant Erwinia Asparaginase (JZP458) in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Who Are Allergic/Hypersensitive to E. coli-Derived Asparaginases
    Maese, Luke
    Loh, Mignon L.
    Lin, Tong
    Aoki, Etsuko
    Zanette, Michelle
    Agarwal, Shirali
    Silverman, Jeffrey A.
    Choi, Mi Rim
    Silverman, Lewis B.
    Raetz, Elizabeth A.
    Rau, Rachel E.
    BLOOD, 2021, 138
12345